Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor indications including p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Solid Tumor

Drugs mentioned

• IMX-110

Snippet

Sponsor: Immix Biopharma Australia Pty Ltd | Conditions: Solid Tumor, Adult, Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN